Betaloc CR (Metoprolol Succinate Tablets) used

Betaloc CR (Metoprolol Succinate Tablets) are used to treat a variety of conditions of the cardiovascular system including, control of hypertension (high blood pressure) by lowering blood pressure to reduce the risk of complications such as stroke and heart attack; management of angina (chest pain) in patients with heart disease; long-term prevention of myocardial infarction (heart attack); treatment of heart failure to improve survival and quality of life; and control of most forms of arrhythmias and dysrhythmias (irregular heart beat or rhythm) and palpitations. Betaloc CR (Metoprolol Succinate Tablets) are also used for preventing migraine, and as a supplementary treatment for hyperthyroidism (overactive thyroid). Betaloc CR (Metoprolol Succinate Tablets) work through a common mechanism in several different body systems to manage the condition and relieve symptoms by reducing heart rate (pulse), workload on the heart (force needed to pump) and oxygen demand by the heart, which increases blood flow and lowers blood pressure.

Betaloc CR (Metoprolol Succinate Tablets) work

Betaloc CR (Metoprolol Succinate Tablets) contain metoprolol, which is a beta-blocker or selective beta 1-receptor antagonist and acts by blocking the action of chemicals called catecholamines, such as adrenaline (epinephrine), which are released by the adrenal glands in response to nerve stimulation during physical and mental stress. Adrenaline works via beta-receptors in the heart to stimulate increased heart rate and constriction (narrowing) of blood vessels. These actions of adrenaline are reduced or inhibited by metoprolol in Betaloc CR (Metoprolol Succinate Tablets), to slow heart rate, dilate (widen) blood vessels, lower blood pressure, and increase blood flow and oxygen to the heart. Since beta-receptors are found in many tissues, particularly the heart, kidneys, vascular smooth muscle in blood vessel walls, lung, skeletal muscle and liver, all short-term and long-term symptom relief due to taking Betaloc CR (Metoprolol Succinate Tablets), is based on blocking beta-receptors in the target tissue. Betaloc CR (Metoprolol Succinate Tablets) are formulated for controlled release so that metoprolol is that released in a sustained and time controlled manner, to ensure a more even effect over 24 hours, which provides better symptom relief with fewer side effects.